ALS’s Investment in Nuvisan

Greenberg Traurig advised ALS Limited on the deal. ALS Limited (ALS) announced the acquisition of a 49 percent equity investment in Nuvisan Group (Nuvisan). Going forward, Nuvisan...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

LivePerson’s Acquisition of e-bot7

Greenberg Traurig advised LivePerson, Inc. on the deal. YPOG advised the shareholders of e-bot7. Nasdaq-listed U.S. company LivePerson, Inc. (Nasdaq: LPSN) announced the acquisition of Munich-based startup...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here